Queensland-based Southern RNA, a leading Contract Development and Manufacturing Organisation (CDMO) specialising in nucleic acid manufacturing, including DNA and mRNA, has announced a strategic partnership with DKSH, a leading Market Expansion Services provider, in India. This partnership marks a significant milestone in Southern RNA's expansion strategies and highlights the burgeoning relationship between the Australian and Indian biotechnology sectors.

The partnership, supported by Trade Investment Queensland (TIQ), the dedicated business agency of the Government of Queensland, perfectly aligns with the state's initiatives to boost local exporters and attract investment and was unveiled at the recently concluded BioAsia 2024 conference in Hyderabad, India.

Through this partnership both Southern RNA and DKSH will foster innovation and growth in the life sciences industry by leveraging DKSH's extensive network and expertise in the Asia Pacific region to introduce Southern RNA's cutting-edge products and services to India's dynamic pharmaceutical landscape. 

India, renowned as a global pharmaceutical powerhouse, presents strategic partnership opportunities and a vast market for Southern RNA's innovative products and services. The collaboration with DKSH is poised to set a precedent for future Australia-India business relations, particularly in the high-growth biotech sector.